Innovus Pharma Announces Formal of a Clinical Advisory Board to Support the Launch of Its Androferti(R) Product in the United States

Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB: INNV), an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and respiratory diseases, has announced today the formation of a Clinical Advisory Board made up of top key opinion leaders in the fields of in vitro fertilization (IVF) lead by Dr. Fady Sharara to support the US launch of its Androferti® product.

Continue Reading
Close Menu